HL Glicomics' IPO subscription concluded its second day schedule around 4 p.m. on the 14th. A total of 184,971 and 22,458 applications were received through KB Securities and IBK Investment Securities, respectively, during the two-day subscription period held on the 13th and 14th.

Based on the minimum subscription amount, the equal allocation shares are 1.56 shares at KB Securities and 1.43 shares at IBK Investment Securities. Both securities firms recorded around one share, meaning subscribers could receive anywhere from one to two shares under the minimum subscription criteria. The proportional competition rates are 1,364.26-to-1 at KB Securities and 1,057.14-to-1 at IBK Investment Securities. Earlier, the institutional investor demand forecast recorded a competition rate of 714.52-to-1.

Meanwhile, market attention is focused on how HL Glicomics will perform on its listing date on the 24th. Given the current market conditions characterized by high volatility, the market sentiment on the day of listing is also an important factor to consider. Excessive optimism or pessimism should be avoided.

According to its regulatory filing, HL Glicomics is engaged in the research and development, manufacturing, processing, storage, and distribution of pharmaceuticals.

[This article is provided for informational purposes to convey market trends and does not constitute investment advice. Investment decisions and their consequences are the sole responsibility of the investor.]